The coexpression of neuropeptides and neurotransmitters in individual neurons encodes a vast set of distinct signals to target cells and ultimately contributes to the functional diversity of the nervous system. The neurobiology of peptidergic systems, however, differs fundamentally from classical transmitter systems. Neuronal bioactive peptide levels are frequently more than two orders of magnitude lower than levels of small molecule neurotransmitters.
Moreover, neuropeptides are synthesized in the neuronal soma and transported to the axon nerve terminals, whereas neurotransmitters are synthesized in the terminals proper (Sossin et al., 1989; Kelly, 1991 Kelly, , 1993 Sudhof and Jahn 1991) . Although these processes are understood, few neuronal systems are directly amenable to experimental studies of the coordinate or differential regulation of neuropeptide and neurotransmitter expression.
Neuropeptide Y (NPY), a highly expressed 36 amino acid c-r-amidated peptide (Tatemoto et al., 1982; Allen et al., 1983; O'Donohue et al., 1985; DeQuidt and Emson, 1986) . and catecholamines are frequently colocalized in cells of sympathoadrenal lineage (O'Donohue et al., 1985; Landis, 1988) . In viva. NPY and catecholamines are co-released from sympathetic neurons and adrenal chromaffin cells (Winkler and Carmichael, 1982; Allen et al., 1984) . Increased neuronal activity elevates plasma levels of sympathetic neuronal NPY and norepinephrine, and activation of the adrenal medulla stimulates both NPY and epinephrine secretion into the circulation (O'Donohue et al., 1985; Lundberg et al., 1986 Lundberg et al., , 1989 . NPY elicits potent dosedependent vasoconstriction and modulates the vasoconstricting actions of norepinephrine (Lundberg et al., 1982; Franco-Cereceda and Lundberg, 1987 CAMP analogs and activators of the CAMP-protein kinase A second messenger pathway increase tyrosine hydroxylase activity, biosynthesis, gene transcription, and mRNA levels (Joh et al., 1978; Lewis et al., 1987 , Zigmond et al., 1989 Kim et al., 1993) . Stimulation of sympathoadrenal cell protein kinase C with phorbol esters increases synthesis of dihydroxyphenylalanine (DOPA), the catecholamine biosynthetic intermediate, and transcription of the tyrosine hydroxylase gene (Zigmond et al., 1989; Vyas et al., 1990; Icard-Liepkalns et al., 1992) . Other regulators, including calcium and calcium ionophores, have been suggested to stimulate the rate of tyrosine hydroxylation and activate tyrosine hydroxylase (Tachikawa et al., 1986; Zigmond et al., 1989) . Regulation of NPY expression has not been as well examined. Pro-NPY mRNA levels are induced in PC I2 cells and N 18TG-2 neuroblastoma cells by activation of either the protein kinase A or protein kinase C pathways, or by stimulation of the glucocorticoid receptor system (Higuchi et al., 1988; Sabol and Higuchi, 1990) . In contrast to the PC I2 and Nl8TG2 cells, pro-NPY mRNA expression in NC lO8-I5 neuroblastoma X glioma hybrid cells is inhibited following protein kinase A activation (Higuchi et al., 1988) .
The results of the few regulatory studies of NPY and catecholamines in primary cultured neuronal cells have often differed from results using tumor cell lines, and may reflect the different cell types or measures examined. Among primary cultured neuron systems, dissociated neurons from the superior cervical ganglion (SCG) have been widely examined (Mains and Patterson, I973a-c; Kessler, 1985; Landis, 1988; Marek and Mains, 1989, 1990) . Most principal neurons of the SCG are catecholaminergic and almost two-thirds of the neurons coexpress norepinephrine and NPY (Jarvi et al., 1986; Hokfelt et al., 1987; Landis, 1988; Freidin et al., 1993) . The high levels of NPY and catecholamine expression in cultured SCG neurons permit regulatory and biosynthetic studies, and cultured isolated SCG neurons have served as a unique model system to investigate the regulation of both neuropeptide and classical transmitter expression in the absence of preganglionic inputs or target cell influences. Unlike the pheochromocytoma and neuroblastoma cell lines, chronic activation of SCG neuron protein kinase A elevates both pro-NPY and tyrosine hydroxylase mRNA levels without affecting neuronal neuropeptide or catecholamine content or biosynthesis (Marek and Mains, 1990; Freidin et al., 1993) . On the other hand, stimulation of protein kinase C decreases SCG neuronal norepinephrine and NPY biosynthesis without altering either pro-NPY or tyrosine hydroxylase mRNA (Marek and Mains, 1990 The mobile phase was cotnposed of 75 mM monochloroacetic acid. pH 3.1, containing 0.67 mM Na,EDTA, 9.26 mM octane sulfonic acid, and 0.5% tetrahydrofuran.
The elution positions of known standards were confirmed using a second solvent system. Catecholamine levels were quantitated by peak area using the peak integration data evaluation program of SMART MANA~'II:R operating software (version I .4l). At a fow rate of IS0 pl/min and an oxidation potential of +0.70 V (50 nA full scale). the catecholamine detection limit (signal two times background) was less than 250 fmol. Standard curves were constructed from the evaluation of five to eight known concentrations of each standard compound, and were linear from less than 250 fmol to over SO pmol of catecholamine or metabolites; sample amine levels were determined by comparison to standard curves. Treatment of the cultures with monoamine oxidase inhibitors or catecholamine uptake inhibitors was detrimental to the cells under long term conditions and was not used in subsequent studies (Sved, 1990 (Fig. IB) . The increased neuronal cell NPY content closely paralleled the increased biosynthesis of NPY and catecholamines reported in previous studies (Mains and Patterson, 1973a~; Marek and Mains, 1989) . At early culture periods, the basal release of NPY material into the culture medium represented a secretory rate of 0.3% of the cellular content/hr, which was comparable to hormonal secretory rates of cultured endocrine cells (May and Eipper, 1986) . As the cellular NPY content increased with time in culture, but secretion remained constant, the secretory rate of NPY expressed as a function of culture NPY content declined to less than 0.05% of cell content/hr.
Matched cultured SCG cells were immunocytochemically stained for NPY to identify whether the population of SCG neurons expressing NPY immunoreactivity increased throughout the 28 d of culture. NPY immunoreactivity was observed in neutonal processes, fiber varicosities and soma of a subpopulation of neurons ( Fig. 2A,B) . Fifty-six percent of the SCG neurons exhibited NPY immunoreactivity throughout the entire culture period, which was similar to values reported for intact adult SCG and cultured neurons (Jarvi et al., 1986 : Hokfelt et al., 1987 : Marek and Mains, 1989 Freidin et al., 1993) . Thus, when the amount of NPY per cell was calculated based on 56% of the population, each neuron contained approximately 0.5 fmol of NPY immunoreactive material after 14 d of culture. The coexpression of NPY and catecholamines in SCG neurons has permitted us to simultaneously examine regulation of both neuropeptide and neurotransmitter content and secretion in individual cell cultures. Primary cultured SCG neuron total catecholamine/metabolite content increased tive-to sixfold by 3 weeks of culture to 17.4 fmol of total catecholamine/metabolite per neuron (data not shown). These levels represented 70%, of adult SCG neuronal catecholamine levels and were in close agreement with previous estimates of maximal SCG catecholamine content in culture (Iacovitti et al., 1982; Kessler, 1985) . The developmental prohle of catecholamine expression was similar to that for norepinephrine biosynthesis (Mains and Patterson. 1973a; 1973b; Marek and Mains, 1989) . While NPY was localized to a subpopulation of sympathetic neurons, the catecholamine biosynthetic enzyme tyrosine hydroxylase was localized in nearly every neuron at all culture times (Fig. 2C) . When SCG neurons were cultured in CSFM, which does not contain the dopamine P-hydroxylase cofactor ascorbate, the ratio of norepinephrine to dopamine in the neurons declined rapidly within 48 hr, reflecting diminished norepinephrine biosynthetic capability and consequential cellular accumulation of dopamine. By day I3 of culture, the cellular content of catecholamines and metabelites (norepinephrine:dopamine:epinephrine:3,4-dihydroxyphenylacetic acid:homovanillic acid or NE:DA:E:DOPAC:HVA) was 3.9: I .0:0.04:0.7:0.8.
Since the ratios of cellular catecholamines and metabolites were stable, even in long term cultures in the absence of added ascorbate, compounds other than ascorbate may also serve as cofactors for dopamine-P-hydroxylase in norepinephrine production. Although norepinephrine was stable in CSFM in the absence of cells, it was rapidly metabolized in the presence of SCG cells; neither norepinephrine nor its metabolites could be measured in conditioned culture medium. While dopamine was rapidly meThe Journal of Neuroscience, June 1995, 15(6) 4583 tabolized to DOPAC and HVA in the presence of SCG cells, the metabolites were stable in the culture medium (Fig. 3A,B) . Greater than 65% of exogenously added dopamine to the SCG cultures was quantitatively recovered as DOPAC and HVA. The accumulation of both metabolites in medium from SCG neuronal cultures was stable throughout the 2448 hr time periods examined for NPY secretion (Fig. 3B) . DOPAC and HVA accumulated in the medium linearly with time at a rate of approximately I l-18 pmol/lOd cells/hr and could be used as an index of SCG catecholamine release into the medium (Fig. 3B.C) .
Depolarization d#erentially increases .syrnpathetic ueurm NPY secretion and medium DOPAC and HVA le,sels
To determine whether SCG neuronal NPY and catecholamine secretion were differentially stimulated by depolarization, cells were cultured in the presence of 40 mM potassium. Depolarization elicited a sustained l&fold increase in the NPY secretory rate (Fig. 4A) . The NPY secretory rate increased from 3.0 fmol/ lOa cells/hr under basal conditions to 54 fmol/lo-' cells/hr in the presence of high potassium concentrations.
There were no apparent changes in neuronal morphology during the treatment period, although treatment periods greater than 96 hr diminished the secretory response.
While depolarization increased the NPY secretory rate 1% fold, incubation of SCG cultures with 40 InM potassium elicited only a threefold increase in medium dopamine metabolite levels, which most likely reflected an augmentation in neuronal catecholamine release (Fig. 4B) . The rate of DOPAC and HVA accumulation increased from a basal 14 pmol/lO' cells/hr to 41 pmol/l Oj cells/hr under depolarizing conditions. The elevated DOPAC and HVA levels were sustained for 96 hr, but like NPY, the levels of stimulation were significantly decreased at time points greater than 96 hr. Although the depolarization-induced increase in medium DOPAC and HVA levels was considerably less than the induced increase in NPY release, this may have resulted from the inherent differences between neuropeptide and catecholamine biosynthesis, uptake, or metabolism.
Regulation qf sympathetic neuron NPY content und secretion is second messenger system speci@ Since activation of different second messenger systems elicits tissue-specific regulation of NPY biosynthesis and mRNA expression, we compared the effects of protein kinase A or protein kinase C activation and calcium ionophores on SCG neuronal NPY content and secretion. Previous studies demonstrated that stimulation of intracellular signaling pathways elicits tissue-specific regulation of neuroendocrine NPY expression. In addition, the reported effects were dependent upon the parameter of NPY expression measured. While treatment of primary SCG cultures with CAMP analogs augmented NPY mRNA levels. neither NPY content nor biosynthesis appeared altered (Marek and Mains, 1990; Freidin et al., 1993) . In contrast, treatment with phorbol esters did not alter NPY mRNA levels, but modestly decreased NPY biosynthesis (Marek and Mains, 1990) . Therefore, the function of protein kinase A or C pathway activation in the regulation of SCG NPY has been uncertain. None of the studies to date, however, examined NPY secretion, which may have contributed to these apparent discrepancies.
Dibutyryl CAMP activation of the protein kinase A second messenger pathway elicited differential effects on SCG culture NPY content and release; NPY secretion was elevated, whereas cellular NPY content was decreased (Fig. SA,B) . NPY secretion Figure 2 . NPY is localized to a stable subpopulation of sympathetic neurons. Cultured SCG neurons were fixed with paraformaldehyde and immunocytochemically stained with 1:50,000 anti-NPY (A, -B) or 1: 10,000 anti-tyrosine hydroxylase (C) using the avidin-biotin-peroxidase complex technique. The number of neurons expressing NPY or enzyme immunoreactivity was determined as described in Materials and Methods. NPY immunoreactivity was localized to the processes, varicosities and soma of 56% of the cultured neurons, whereas tyrosine hydroxylase immunoreactivity was observed in nearly all of the cells. Arrowheads, Unstained neurons.
was increased maximally over IO-fold from 2.2 fmol/lo4 cells/ hr to 35 fmol/lo4 cells/hr with 3.2 mM dBcAMP (Fig. 5A) . At dBcAMP concentrations that maximally stimulated secretion, cellular NPY content was diminished from 7.7 pmol/l04 cells to 4.9 pmoV104 cells (Fig. 5B) . Low concentrations of dBcAMP (100 pM) increased sympathetic neuronal NPY content approximately 20% compared to control cells, suggesting that low but sustained stimulation may increase NPY synthesis and storage. Total SCG NPY production in the dBcAMP-treated cultures (cumulative secreted NPY plus cellular NPY content) was greater than control cultures, and suggested increased NPY biosynthesis following protein kinase A stimulation. Sustained stimulated secretion was observed in cultures treated with dBcAMP for 21 d (data not shown).
Similar sustained stimulatory responses were elicited following activation of the CAMP-protein kinase A pathway with forskolin. The diterpene compound forskolin, which activates the catalytic subunit of adenylyl cyclase, maximally increased SCG neuronal NPY secretion approximately fivefold (Fig. 5C) ; secretion increased from 6.6 fmol NPY/lW cells& to 34 fmol NPY/l04 cells/hr with 10 FM forskolin. Consistent with dBc-AMP-elicited decreased cellular NPY, forskolin diminished sympathetic neuronal NPY content 45% at concentrations that maximally stimulated secretion, suggesting that maximal stimulatory secretory rates exceeded the biosynthetic rates leading to depletion of intracellular neuropeptide stores (Fig. 5D ). Increasing cellular CAMP levels following ADP-ribosylation of the guanine nucleotide binding protein G, with cholera toxin increased NPY release approximately fourfold with all the concentrations tested (0.1 rig/ml to 10 p,g/ml); the effects of pertussis toxin were much lower, eliciting less than a twofold increase in NPY secretion (data not shown).
Activation of the diacylglycerol-protein kinase C pathway with the phorbol ester PMA stimulated sustained SCG neuronal NPY secretion, but to a lesser degree than activation of protein kinase A (Fig. 6A) . Maximal stimulated release was attained with 32 nM PMA. Concentrations of PMA higher than 32 nM diminished the levels of stimulated secretion. Unlike protein kinase A stimulation, activation of the protein kinase C pathway did not change SCG cellular NPY levels at any concentration of PMA (Fig. 6B) ; consequently, total NPY production (cumulative secreted NPY plus cellular NPY content) was augmented by PMA. The differences in cellular NPY levels between d BcAMP and PMA treated cultures may be a consequence of the differential regulation of neuropeptide production/secretion coupling between the two intracellular second messenger pathways.
NPY secretion induced by the calcium ionophore A23 187 was paralleled by a concomitant decrease in cellular NPY (Fig.  6C,D) . A23187 maximally stimulated NPY release less than threefold; secretion increased from 5.5 fmol NPY/lW cellsihr in control neurons to 15 fmol NPY/I04 cell&r with 100 nM A23 187 (Fig. 6C) . The calcium ionophore decreased the cellular NPY content (Fig. 60 ) equivalent to the amount of NPY secreted. Neuronal NPY levels were decreased more than 50% with 32 nM A23187 compared to control cells; 100 nM A23187 decreased cellular NPY content to 20% of control. A23187 did Time (days) Figure 3 . Accumulation of the catecholamine metabolites DOPAC and HVA in SCG culture medium is stable and linear with time. Sympathetic neurons plated at an initial density of 1.5 X 10' cells/cm' were cultured in 250 pl medium/l .5 X IO-' cells beginning on day Y following plating. The conditioned medium was analyzed for monoamine and metabolite levels using electrochemical detection coupled to reversed phase HPLC with a monochloroacetic acid/octane sulfonic acidltetrahydrofuran solvent system. The HPLC profile showed that the primary catecholamine metabolites in the conditioned medium were DOPAC and HVA (A). At the indicated times, the conditioned medium was removed for metabolite assay (B). Accumulation of both metabolites was stable across the 48 hr times used for NPY analysis. Separate cultures were incubated in CSFM for I4 d beginning on day 9 of culture (C); the conditioned medium was collected for metabolite analysis and replaced with fresh CSFM each 48 hr. Data represent the mean total (B) or cumulative (C) nanomoles of DOPAC plus HVA per lOa cells from four to five cultures i SEM. NE, Norepinephrine: E, epinephrine; DOPAC, 3,3-dihydroxyphenylacetic acid; DA, dopamine; HVA. homovanillic acid.
not change total NPY production (cumulative NPY secreted plus culture NPY content) from control cultures, whereas activation of the protein kinase A or protein kinase C pathways increased total NPY. These results suggested that under our culture conditions, the calcium ionophore had no apparent effects on NPY synthesis. Cultured neurons are acutely sensitive to cellular calcium levels (Johnson et al., 1992) , and under current culture conditions, continuous treatment of the cultures for more than 4 d with concentrations of A231 87 of 1 pM or greater were cytotoxic.
Symputhetic neuron NPY and catecholamine content and secretion we difSeretltially reguluted
To directly compare the regulation of NPY and catecholamine release from SCG neurons, cultures were treated with a maximal effective dose of each second messenger system activator. The conditioned medium from individual cultures was assayed for both NPY and catecholamines.
Activation of the protein kinase A pathway with either dBcAMP or forskolin elicited parallel neuronal NPY and catecholamine release (Fig. 7A,C) . Similar increases in NPY immunoreactivity and dopamine metabolite levels in SCG neuron conditioned medium suggested similar regulation of both neurotransmitter and neuropeptide secretion with protein kinase A activation.
Unlike protein kinase A stimulation, medium DOPAC and HVA levels were unchanged at 48 hr (data not shown) and increased to 160% of control following 96 hr of treatment with PMA (Fig. 7C) . In contrast, PMA increased NPY secretion to over 300% of control at both times (Fig. 7A) . Medium DOPAC and HVA levels from cultures treated with the calcium ionophore A23187 were reduced to approximately 65-80% of control levels, whereas NPY release was increased to approximately 200-300% of control. The differential regulation of neuropeptide and neurotransmitter was more dramatic in the changes elicited in the intracellular levels. Maxima1 activation of the protein kinase A pathway decreased NPY content to approximately 4045% of control, but increased total catecholamine content to 175-300% of . Depolarization increases sympathetic neuron NPY secretion and medium catecholamine metabolite levels. Dissociated SCG cells were plated at an initial density of 1.5 X I O1 cells/cm'. Nine days after plating, SCG neurons were incubated in 250 pl CSFM/l.S X lOJ cells containing 40 mM NaCl (control, 0) or 40 mM KCI (high potassium, H) for 96 hr. Each 24 hr, conditioned medium was collected for NPY radioimmunoassay and catecholamine metabolite analysis, and replaced with fresh medium containing NaCl or KC]. Data represent the mean cumulative pmol of NPY immunoreactivity secreted per IO' cells or nmol total catecholamine metabolite per IO' cells from five cultures +-SEM.
control (Fig. 7&D) . Activation of the protein kinase C pathway resulted in no change in NPY levels, but increased total catecholamines by 20%. Calcium mobilization decreased NPY content to 50% of control, whereas total catecholamine was unaltered. Furthermore, activation of each of these second messenger systems differentially regulated each of the catecholamines and metabolites (Fig. 8) . For example, stimulation of protein kinase A decreased cellular norepinephrine, but increased neuronal dopamine, epinephrine, DOPAC, and HVA; A23187 also decreased norepinephrine, but increased dopamine, epinephrine, DOPAC, and HVA leading to a net unaltered total cellular catecholamine level. The increase in dopamine content most likely reflected increased catecholamine biosynthesis in the absence of the dopamine-P-hydroxylase cofactor, ascorbic acid, and the increase in DOPAC may be indicative of elevated dopamine turnover. Many studies, however, have also demonstrated augmented neurotransmitter uptake by transporters following increased synaptic activity and activation of specific intracellular signaling mechanisms including CAMP-protein kinase A (Kadowaki et al., 1990; Desnos et al., 1992; Amara and Kuhar, 1993) . The increases in cellular DOPAC and HVA may have reflected increased neuronal catecholamine reuptake and metabolism, although the mechanisms underlying the changes in cellular dopamine metabolite levels remain to be investigated.
Discussion
Cultured superior cervical ganglion neurons have been a well studied in vitro neuronal system with respect to neuronal survival, development, degeneration, neurotransmitter production, neuropeptidergic expression, neurochemical phenotypic plasticity, and receptor-mediated functions. The high levels of catecholamine and NPY expression in primary SCG cultures permit a direct means of examining how environmental conditions and regulatory factors coordinately or independently regulate transmitter and bioactive peptide production in neuronal cells. Although neuronal secretion is one of the defining parameters of neuronal function, catecholamine and NPY release in SCG cultures has not been examined previously. In our current studies we characterized NPY and catecholamine secretion from cultured SCG neurons and identified secretion as a central point of regulation of peptide and transmitter expression. Furthermore, we demonstrated second messenger system specitic differential regulation of neuronal NPY and catecholamine content and release.
We have analyzed NPY and catecholamine levels in microcultures and conditioned medium, and established for the first time SCG neuron basal and stimulated peptide and transmitter secretory rates. When primary SCG neurons were cultured in defined medium (1.5 X I (r cells/cm'; 250 pl of defined medium/ 1.5 X IO4 cells), basal NPY secretion was approximately 0.9-3 fmol/l(r cells/hr, whereas catecholamine release was about IO-20 pmol/l04 cells/hr. Secretion of both peptide and transmitter was constant over time in culture.
The basal NPY secretory rate, expressed as a function of neuronal NPY content, diminished as cellular neuropeptide levels increased with time in culture. Basal NPY secretion was less than 0.05% of cell content/hr in mature cultures, which is relatively low compared to neuronal tumor cell lines and endocrine cells. However, this is similar to the results of Marek and Mains (1989, 1990) , who reported that less than 0.05% of biosynthetically labeled NPY material/hr accumulated in conditioned medium from cultured SCG neurons. These low basal secretory rates are not due to peptide metabolism, since NPY is stable in conditioned medium (Marek and Mains, 1989) , but instead are indicative of low basal secretion in unstimulated cultures. The low basal rates suggest that the primary determinants of NPY secretion are dependent essentially on the interactions of exogenous neuroregulatory signals. By birth, nearly all of the principal neurons of the SCG express catecholaminergic markers and synthesize predominantly norepinephrine (Hendry, 1977; Landis, 1988) . During early development, many SCG neurons exhibit concomitant expression of NPY, and SCG levels of catecholamine and NPY increase in parallel more than IO-fold during postnatal development. Our primary cultured SCG neurons exhibited similar parallel increased cellular NPY and catecholamine content. NPY and norepinephrine biosynthesis display comparable developmental profiles (Mains and Patterson, l973b; Marek and Mains, 1989) , 1986; Landis, 1988) . Approximately 50% of the neuronal population of mature KG cultures also contain NPY (Marek and Mains, 1989) . We observed a stable population (56%) of NPY immunoreactive neurons throughout the developmental time course of the cultures and therefore, the elevated NPY content in mature cultures was due to an increase in NPY per neuron, not an increase in the number of neurons expressing NPY. Substances that regulate neuronal transmitter and peptide expression arise from a variety of sources including presynaptic signals, hormones, glial and supporting cell factors, hematopoietic factors and target tissue factors (Landis, 1988; Patterson and Nawa, 1993) . The effects of presynaptic inputs to the SCG, that is depolarization, elicited sustained stimulated NPY and catecholamine secretion from cultured neurons; NPY release was stimulated greater than catecholamine secretion. Depolarization has also been shown to modulate SCG neuronal NPY and tyrosine hydroxylase mRNA and biosynthesis, as well as neurochemical phenotypic expression (Zigmond et al., 1989; Sun et al., 1992) .
Stimulated secretory rates appear to be important components of second messenger system regulation of SCG neuropeptide and neurotransmitter expression. Activation of intracellular signaling pathways had specific and differential effects on NPY and catecholamine content and release. In previous studies, protein kinase A pathway activation increased N 18TG-2 neuroblastoma and PC 12 pheochromocytoma cell pro-NPY mRNA levels (Higuchi et al., 1988) ; SCG neuronal pro-NPY and tyrosine hydroxylase mRNA were increased approximately 50% by dBcAMP whereas NPY and norepinephrine biosynthesis was unchanged (Marek and Mains, 1990) . Since SCG culture NPY content was also unaltered by CAMP analogs (Freidin et al., 1993) , the role of the CAMP-protein kinase A pathway in SCG NPY expression has remained unclear. We have shown that a primary neuronal response to CAMP-protein kinase A activation was stimulated secretion, which may account for the previous apparent discrepancies. NPY and catecholamine secretion was concomitantly increased over 500% by protein kinase A activation. Cellular NPY content remained relatively unchanged while NPY secretion was elevated under moderate stimulatory conditions, suggesting that NPY biosynthesis and secretion may be closely coupled to maintain constant cellular neuropeptide levels. Under maximally stimulated secretory conditions, SCG cellular NPY content was diminished approximately 40-45%, indicating that neuronal secretion exceeded cellular neuropeptide production levels. In contrast, SCG culture total catecholamine content (NE + DA + E + DOPAC + HVA) increased in concert with catecholamine release in response to CAMP-protein kinase A activation. SCG neuronal dopamine levels were elevated, and most likely reflected stimulated dopamine biosynthesis in cells cultured in the absence of ascorbate, and the elevated DOPAC and HVA levels may have reflected increased reuptake and/or metabolism. Under moderately stimulatory concentrations of dBcAMP or forskolin, cellular norepinephrine was unaltered, whereas at maximally stimulatory concentrations, norepinephrine levels were decreased. In other studies, norepinephrine biosynthesis in SCG neurons cultured in the presence of ascorbate was unchanged following dBcAMP treatment (Marek and Mains, 1990 ). The differences in SCG NPY and catecholamine content following stimulation of the cAMP-protein kinase A pathway may reflect differential cellular responses to a common regulator.
The regulation of sympathetic neuron NPY expression was also second messenger system specific. Activation of the protein kinase C pathway with PMA stimulated SCG neuronal NPY secretion, but to a lesser degree than activation of protein kinase A. Unlike protein kinase A stimulation, activation of protein kinase C did not change cellular NPY levels at any PMA concentration. Furthermore, stimulation of the two intracellular signaling pathways produced different patterns of sympathetic neuronal catecholamine levels and secretion. Catecholamine and metabolite levels in neurons and conditioned medium were minimally increased or unchanged by protein kinase C activation. In contrast, stimulation of the protein kinase A pathway increased both total catecholamine/metabolite content and release; neuronal NPY levels were decreased under identical conditions.
Chronic treatment with PMA has been shown to increase pro-NPY mRNA levels and DOPA synthesis in PC12 pheochromocytoma cells (Higuchi et al., 1988; Zigmond et al., 1989; Sabol and Higuchi, 1990) . On the other hand, primary cultured SCG neurons under comparable treatment paradigms displayed no changes in either pro-NPY or tyrosine hydroxylase mRNA, but exhibited diminished NPY and norepinephrine biosynthesis (Marek and Mains, 1989) . In our studies, PMA stimulated NPY secretion, but did not alter neuronal NPY content, whereas cellular and released catecholamine and metabolite levels were unchanged or minimally increased. Moreover. the effects of long term PMA treatment on the downregulation of SCG neuronal protein kinase C and the consequences of these changes for NPY or catecholamine production has not been investigated. Modulation of intracellular calcium levels has been shown to regulate a variety of cellular functions in different neuroendocrine cell types. Long term treatment of PC12 and neuroblastoma cell lines with the calcium ionophore A23187 modestly increased pro-NPY mRNA expression, but augmented neuropeptide mRNA levels dramatically upon concerted treatment with other secretagogues (Higuchi and Sabol. 1988 ). In our studies, NPY secretion induced by A23 I87 was paralleled by a concomitant decrease in cellular NPY. Activation of the protein kinase A and C pathways increased total NPY production (cumulative NPY secreted plus cellular NPY content), whereas A23187 did not change total NPY. The effects of A23 187 on NPY expression therefore appear to be primarily secretory. In contrast to its effects on NPY expression. A23 I87 reduced catecholamine secretion without changing cellular content, and may reflect changes in SCG neurotransmitter biosynthesis, uptake, and metabolism. Excessive calcium influx has been suggested to mediate excitotoxic death of neurons (Choi, 1988; Johnson, 1992 (Thureson-Klein, 1983; Fried et al., 1985; Kelly, 1993) ; synaptic vesicles contain classical neurotransmitters, whereas secretory granules contain neuropeptides. In sympathetic neurons, synaptic vesicles comprise approximately 95% of the vesicle population, while peptide-containing secretory granules represent only 5% of the population (Thureson-Klein, 1983; Fried et al., 1985) . Catecholamines are synthesized at the axon terminal, where synaptic vesicles are refilled by an uptake mechanism. These vesicles then either dock along the plasma membrane in preparation for release, or are translocated to the reserve pool (Sossin et al., 1989; Sudhof and Jahn, 1991; Kelly, 1991 Kelly, , 1993 . In contrast, neuropeptides are synthesized at sites distant from the terminal and following release, secretory granule membranes are recycled to the Golgi complex. The existence of a readily releasable or reserve pool of secretory granules and the details of granule mobilization remain uncertain. Differences in the biosynthetic pathways, vesicular compartmentalization, storage, uptake, and metabolism of neuropeptides and neurotransmitters support independent mechanisms of NPY and catecholamine regulation. Low frequency stimulation of the splenic nerve, for example, preferentially releases catecholamine from synaptic vesicles, while NPY secretion from secretory granules is dependent on higher stimulatory frequencies and patterns (Lundberg et al., 1986) . In our studies, the SCG neuronal basal catecholamine secretory rate was over 5000-fold higher than that for NPY, the secretory rates of NPY and catecholamines expressed as a percentage of the cell content were approximately 0.05% and lo%, respectively. The differences in these basal secretory rates may be related to the functional compartmentalization, relative vesicle population sizes and independent biosynthetic pathways of neuropeptides and neurotransmitters. Moreover, the differences in depolarization-induced release of NPY and catecholamine (1 g-fold vs 3-fold, respectively) may be related to higher basal catecholamine secretion and slower NPY turnover. The two neurochemicals demonstrated importanf differences not only in the regulation of secretory responses, but also in the regulation of intracellular peptide and transmitter profiles. Again, the differential regulation of neuronal NPY and catecholamine content by specific intracellular signaling pathways may represent fundamental differences in sites of biosynthesis, biosynthetic rates, vesicle populations, storage, uptake, metabolism, and release mechanisms.
In summary, the current studies have demonstrated independent regulation of sympathetic neuronal NPY and catecholamine content and release. We have established the basal secretory rates for the primary transmitter and peptide in principal neurons of the SCG, and demonstrated that secretion of both NPY and catecholamines was differentially stimulated by depolarization. Activation of intracellular signaling pathways was shown to be an important point of regulation of sympathetic neuropeptide and neurotransmitter content and release. Regulation was second messenger system specific; stimulation of protein kinase A, protein kinase C, or intracellular calcium differentially affected SCG neuron NPY and catecholamine content and secretion. Th magnitude of the secretory responses of SCG neurons to thes regulators was far greater than other components of NPY c catecholamine expression, including content, biosynthesis an mRNA levels, suggesting that release is a primary site of mod ulation. Consequently, sympathetic neuron secretion may be sensitive indicator of peptide or transmitter expression, and a important measure to consider in understanding the mechanism of regulation. The independent control of sympathetic neurons NPY and catecholamine content and release is consistent wit the differential biosynthetic pathways, vesicular compartmental ization, storage, uptake, and metabolism of neuropeptides versu neurotransmitters.
